Expression Profiling of Circulating Tumor Cells in Pancreatic Ductal Adenocarcinoma Patients: Biomarkers Predicting Overall Survival
Published 2019 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Expression Profiling of Circulating Tumor Cells in Pancreatic Ductal Adenocarcinoma Patients: Biomarkers Predicting Overall Survival
Authors
Keywords
-
Journal
Frontiers in Oncology
Volume 9, Issue -, Pages -
Publisher
Frontiers Media SA
Online
2019-09-10
DOI
10.3389/fonc.2019.00874
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Circumventing senescence is associated with stem cell properties and metformin sensitivity
- (2019) Xavier Deschênes-Simard et al. AGING CELL
- Cancer statistics, 2019
- (2019) Rebecca L. Siegel et al. CA-A CANCER JOURNAL FOR CLINICIANS
- Molecular detection of epithelial-mesenchymal transition markers in circulating tumor cells from pancreatic cancer patients: Potential role in clinical practice
- (2019) Xiao-Hui Zhao et al. WORLD JOURNAL OF GASTROENTEROLOGY
- High tumor cell vimentin expression indicatesprolonged survival in patients with ovarian malignant tumors
- (2019) Sebastian Szubert et al. Ginekologia Polska
- Retraction notice to “CD133+/CD44+/Oct4+/Nestin+ stem-like cells isolated from Panc-1 cell line may contribute to multi-resistance and metastasis of pancreatic cancer” [Acta Histochemica 115 (2013) 349–356]
- (2018) Dongqing Wang et al. ACTA HISTOCHEMICA
- Corrigendum to “Clinical impact of circulating tumor cells and therapy response in pancreatic cancer” [43 (6) (2017) 1050–1055]
- (2018) Keishi Okubo et al. EJSO
- Liquid Biopsy in Rare Cancers: Lessons from Hemangiopericytoma
- (2018) Chiara Nicolazzo et al. Analytical Cellular Pathology
- Cell fusion potentiates tumor heterogeneity and reveals circulating hybrid cells that correlate with stage and survival
- (2018) Charles E. Gast et al. Science Advances
- Molecular Drivers of Pancreatic Cancer Pathogenesis: Looking Inward to Move Forward
- (2017) Mohammad Khan et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Filtration-based enrichment of circulating tumor cells from all prostate cancer risk groups
- (2017) Julius Adebayo Awe et al. UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS
- Tumacrophage: macrophages transformed into tumor stem-like cells by virulent genetic material from tumor cells
- (2017) Yizhuang Zhang et al. Oncotarget
- Stromal Expression of Vimentin Predicts the Clinical Outcome of Stage II Colorectal Cancer for High-Risk Patients
- (2017) Li-guo Liu et al. MEDICAL SCIENCE MONITOR
- Circulating Tumor Cell Phenotype Predicts Recurrence and Survival in Pancreatic Adenocarcinoma
- (2016) Katherine E. Poruk et al. ANNALS OF SURGERY
- Synergistic effects of CD44 and TGF-β1 through AKT/GSK-3β/β-catenin signaling during epithelial-mesenchymal transition in liver cancer cells
- (2016) Na Ri Park et al. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
- Circulating tumour cells as a biomarker for diagnosis and staging in pancreatic cancer
- (2016) J S Ankeny et al. BRITISH JOURNAL OF CANCER
- KRAS mutation associated with CD44/CD166 immunoexpression as predictors of worse outcome in metastatic colon cancer
- (2016) Karen Bento Ribeiro et al. Cancer Biomarkers
- Clinical Significance of Circulating Tumor Microemboli as a Prognostic Marker in Patients with Pancreatic Ductal Adenocarcinoma
- (2016) M.-C. Chang et al. CLINICAL CHEMISTRY
- CTC clusters in cancer progression and metastasis
- (2016) Anna Fabisiewicz et al. MEDICAL ONCOLOGY
- Downregulation of vimentin expression increased drug resistance in ovarian cancer cells
- (2016) Yi Huo et al. Oncotarget
- Pancreatic cancer cell invasion: mesenchymal switch or just hitchhiking?
- (2016) Rémi Samain et al. Translational Cancer Research
- CD44high/ALDH1highhead and neck squamous cell carcinoma cells exhibit mesenchymal characteristics and GSK3β-dependent cancer stem cell properties
- (2015) Sayaka Seino et al. JOURNAL OF ORAL PATHOLOGY & MEDICINE
- Circulating Tumor Cells Found in Patients With Localized and Advanced Pancreatic Cancer
- (2015) Birte Kulemann et al. PANCREAS
- Addressing the challenges of pancreatic cancer: Future directions for improving outcomes
- (2015) Manuel Hidalgo et al. PANCREATOLOGY
- VEGF-B promotes cancer metastasis through a VEGF-A–independent mechanism and serves as a marker of poor prognosis for cancer patients
- (2015) Xiaojuan Yang et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Epithelial-Mesenchymal Transitioned Circulating Tumor Cells Capture for Detecting Tumor Progression
- (2014) A. Satelli et al. CLINICAL CANCER RESEARCH
- Circulating tumour cells in metastatic head and neck cancers
- (2014) Arutha Kulasinghe et al. INTERNATIONAL JOURNAL OF CANCER
- Circulating Tumor Cells as a Biomarker of Response to Treatment in Patient-Derived Xenograft Mouse Models of Pancreatic Adenocarcinoma
- (2014) Robert J. Torphy et al. PLoS One
- Antidiabetic Drug Metformin Prevents Progression of Pancreatic Cancer by Targeting in Part Cancer Stem Cells and mTOR Signaling
- (2014) Altaf Mohammed et al. Translational Oncology
- Usefulness of Circulating Tumor Cell Detection in Pancreatic Adenocarcinoma Diagnosis
- (2013) Isabelle Iwanicki-Caron et al. AMERICAN JOURNAL OF GASTROENTEROLOGY
- Circulating tumor cells: Advances in isolation and analysis, and challenges for clinical applications
- (2013) Ramdane Harouaka et al. PHARMACOLOGY & THERAPEUTICS
- Prognostic value of circulating tumor cells in patients with pancreatic cancer: a meta-analysis
- (2013) Lu Han et al. TUMOR BIOLOGY
- Pancreatic cancer circulating tumour cells express a cell motility gene signature that predicts survival after surgery
- (2012) Gregory Sergeant et al. BMC CANCER
- Enhancement of the Antiproliferative Activity of Gemcitabine by Modulation of c-Met Pathway in Pancreatic Cancer
- (2012) Amir Avan et al. CURRENT PHARMACEUTICAL DESIGN
- A pilot study to explore circulating tumour cells in pancreatic cancer as a novel biomarker
- (2011) L Khoja et al. BRITISH JOURNAL OF CANCER
- Vimentin in cancer and its potential as a molecular target for cancer therapy
- (2011) Arun Satelli et al. CELLULAR AND MOLECULAR LIFE SCIENCES
- Gemcitabine Plusnab-Paclitaxel Is an Active Regimen in Patients With Advanced Pancreatic Cancer: A Phase I/II Trial
- (2011) Daniel D. Von Hoff et al. JOURNAL OF CLINICAL ONCOLOGY
- FOLFIRINOX versus Gemcitabine for Metastatic Pancreatic Cancer
- (2011) Thierry Conroy et al. NEW ENGLAND JOURNAL OF MEDICINE
- Epidermal Growth Factor Receptor in Pancreatic Cancer
- (2011) Melissa Oliveira-Cunha et al. Cancers
- ALCAM is associated with chemoresistance and tumor cell adhesion in pancreatic cancer
- (2010) Xin Hong et al. JOURNAL OF SURGICAL ONCOLOGY
- Pancreatic Cancer
- (2010) Manuel Hidalgo NEW ENGLAND JOURNAL OF MEDICINE
- Suppressive Effects of Vascular Endothelial Growth Factor-B on Tumor Growth in a Mouse Model of Pancreatic Neuroendocrine Tumorigenesis
- (2010) Imke Albrecht et al. PLoS One
- Increased expression of ALCAM/CD166 in pancreatic cancer is an independent prognostic marker for poor survival and early tumour relapse
- (2009) C Kahlert et al. BRITISH JOURNAL OF CANCER
- CD44 and EpCAM: Cancer-Initiating Cell Markers
- (2008) Rachid Marhaba et al. CURRENT MOLECULAR MEDICINE
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started